rs4244610

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004260.4(RECQL4):​c.3236+13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.467 in 1,599,570 control chromosomes in the GnomAD database, including 177,531 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 14483 hom., cov: 35)
Exomes 𝑓: 0.47 ( 163048 hom. )

Consequence

RECQL4
NM_004260.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.90

Publications

17 publications found
Variant links:
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
RECQL4 Gene-Disease associations (from GenCC):
  • Baller-Gerold syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
  • Rothmund-Thomson syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Rothmund-Thomson syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • osteosarcoma
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • rapadilino syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 8-144512131-G-A is Benign according to our data. Variant chr8-144512131-G-A is described in ClinVar as Benign. ClinVar VariationId is 94893.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.569 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RECQL4NM_004260.4 linkc.3236+13C>T intron_variant Intron 18 of 20 ENST00000617875.6 NP_004251.4 O94761

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RECQL4ENST00000617875.6 linkc.3236+13C>T intron_variant Intron 18 of 20 1 NM_004260.4 ENSP00000482313.2 O94761

Frequencies

GnomAD3 genomes
AF:
0.421
AC:
63981
AN:
152070
Hom.:
14478
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.252
Gnomad AMI
AF:
0.269
Gnomad AMR
AF:
0.522
Gnomad ASJ
AF:
0.427
Gnomad EAS
AF:
0.467
Gnomad SAS
AF:
0.588
Gnomad FIN
AF:
0.499
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.474
Gnomad OTH
AF:
0.453
GnomAD2 exomes
AF:
0.490
AC:
112458
AN:
229620
AF XY:
0.493
show subpopulations
Gnomad AFR exome
AF:
0.247
Gnomad AMR exome
AF:
0.571
Gnomad ASJ exome
AF:
0.455
Gnomad EAS exome
AF:
0.465
Gnomad FIN exome
AF:
0.498
Gnomad NFE exome
AF:
0.479
Gnomad OTH exome
AF:
0.475
GnomAD4 exome
AF:
0.472
AC:
682849
AN:
1447382
Hom.:
163048
Cov.:
56
AF XY:
0.476
AC XY:
341743
AN XY:
718472
show subpopulations
African (AFR)
AF:
0.242
AC:
8039
AN:
33262
American (AMR)
AF:
0.558
AC:
24136
AN:
43226
Ashkenazi Jewish (ASJ)
AF:
0.445
AC:
11503
AN:
25862
East Asian (EAS)
AF:
0.413
AC:
16196
AN:
39256
South Asian (SAS)
AF:
0.565
AC:
48191
AN:
85232
European-Finnish (FIN)
AF:
0.496
AC:
24929
AN:
50262
Middle Eastern (MID)
AF:
0.362
AC:
2084
AN:
5750
European-Non Finnish (NFE)
AF:
0.471
AC:
520263
AN:
1104784
Other (OTH)
AF:
0.460
AC:
27508
AN:
59748
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
21319
42639
63958
85278
106597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15438
30876
46314
61752
77190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.421
AC:
64001
AN:
152188
Hom.:
14483
Cov.:
35
AF XY:
0.427
AC XY:
31765
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.252
AC:
10463
AN:
41548
American (AMR)
AF:
0.523
AC:
7996
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.427
AC:
1481
AN:
3466
East Asian (EAS)
AF:
0.466
AC:
2412
AN:
5176
South Asian (SAS)
AF:
0.587
AC:
2835
AN:
4826
European-Finnish (FIN)
AF:
0.499
AC:
5291
AN:
10594
Middle Eastern (MID)
AF:
0.425
AC:
124
AN:
292
European-Non Finnish (NFE)
AF:
0.474
AC:
32200
AN:
67960
Other (OTH)
AF:
0.451
AC:
954
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1863
3727
5590
7454
9317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
600
1200
1800
2400
3000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.444
Hom.:
2851
Bravo
AF:
0.414
Asia WGS
AF:
0.534
AC:
1856
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 08, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Baller-Gerold syndrome Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rapadilino syndrome Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rothmund-Thomson syndrome type 2 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.094
DANN
Benign
0.90
PhyloP100
-1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4244610; hg19: chr8-145737514; COSMIC: COSV56739218; COSMIC: COSV56739218; API